Featured
Last news
Brenmiller Energy Ltd. Announces Expected Implementation of 7-for-1 Reverse Share Split
ROSH HA'AYIN, ISRAEL / ACCESS Newswire / January 21, 2026 / Brenmiller Energy Ltd. ("Brenmiller", "Brenmiller Energy" or the "Company") (Nasdaq:BNRG), a leading global provider of Thermal Energy Storage ("TES") solutions for industrial and utility customers, today announced that a reverse share split of its issued and outstanding ordinary shares, no par value per share (the "Ordinary Shares") at a ratio of 7-for-1 is expected to be implemented after market close on January 23, 2026. The Company's Ordinary Shares will begin trading on the Nasdaq Capital Market on a post-split basis at the market open on January 26, 2026 under the Company's existing trading symbol "BNRG".
Trustpoint Xposure Completes Rigorous Training and Independent Testing to Lead AI Search Visibility in 2025
AI Visibility is No Longer Experimental
Black Book Research Publishes 2026-2027 Update: "Global Growth Opportunities for openEHR Adoption"
Updated analysis shows procurement moving toward data that outlives the application, with openEHR + HL7 FHIR emerging as a pragmatic target pattern for exchange and longitudinal persistence.
TridentCare Announces Acquisition of DispatchHealth's Imaging Business Unit
Purchase expands and strengthens TridentCare's capabilities in several key markets and will enhance customer and patient experience.
Various Ventures Presenting at the 3rd Annual DealFlow Discovery Conference
ATLANTIC CITY, NJ / ACCESS Newswire / January 21, 2026 / Various Ventures, an incubator in the SAAS today announced that it will participate in the DealFlow Discovery Conference, taking place January 28-29, 2026.
Medical Care Technologies Inc. (OTC Pink:MDCE) Completes Marketing Content for First AI-Based Lifestyle App Ahead of Imminent Launch
Milestone Achieved as Company Lays Foundation for a Broad Portfolio of AI-Based Lifestyle, Wellness, and Medical Applications in 2026 and Beyond
Revelation Biosciences Reaches Agreement with FDA on Gemini Approval Pathway for AKI
- Single Phase 2/3 Adaptive Study Design -- Clinically Relevant, Objective Composite Endpoint -
Specificity Secures Strategic Short-Term Capital Through STRATA Financing to Accelerate Growth and Tech Buildout
SARASOTA, FLORIDA / ACCESS Newswire / January 21, 2026 / Specificity (OTCID:SPTY), a leading hybrid AdTech company revolutionizing digital marketing with bot-free, intent-based targeting and precision audience solutions, today announced that it has successfully utilized its active STRATA Agreement to bring in short-term capital. This financing vehicle supports the company's ongoing efforts to scale operations while preparing for a full capital round.
Grown Rogue Presenting at the 3rd Annual DealFlow Discovery Conference
ATLANTIC CITY, NJ / ACCESS Newswire / January 21, 2026 / Grown Rogue International Inc. ("Grown Rogue" or the "Company") (CSE:GRIN)(OTC:GRUSF), a flower-forward cannabis company combining craft values with disciplined execution, today announced that it will participate in the DealFlow Discovery Conference, taking place January 28-29, 2026.
Aspire Biopharma's Unveils Bold New Era for BUZZ BOMB(TM) Caffeine with Dynamic Website and Packaging Redesign
New streamlined, mobile-optimized shopping experience, allows consumers to purchase BUZZ BOMB™ directly, access exclusive promotions and engage with the brand through educational and lifestyle content highlighting the benefits of sublingual delivery
Ensysce Biosciences Expands Global Opioid Patent Portfolio
~ TAAP™ and MPAR® technologies extended across opioid products to advance safer pain treatment ~
OBOOK Holdings Inc. ($OWLS) Presenting at the 3rd Annual DealFlow Discovery Conference
ARLINGTON, VA AND ATLANTIC CITY, NJ / ACCESS Newswire / January 21, 2026 / OBOOK Holdings Inc. (NASDAQ:OWLS) ("OwlTing" or the "Company"), a blockchain technology company operating as the OwlTing Group, today announced that it will participate in the DealFlow Discovery Conference, taking place January 28-29, 2026.
American Critical Resources Presenting at the 3rd Annual DealFlow Discovery Conference
ATLANTIC CITY, NJ AND IMPERIAL COUNTY, CA / ACCESS Newswire / January 21, 2026 / American Critical Resources ("ACR"), a U.S. critical minerals and renewable energy company, today announced participation in the DealFlow Discovery Conference on January 28-29, 2026.
Reservoir Media to Release Third Quarter Fiscal Year 2026 Results on February 4, 2026
NEW YORK, NY / ACCESS Newswire / January 21, 2026 / Reservoir Media, Inc. (NASDAQ:RSVR) ("Reservoir" or the "Company"), an award-winning independent music company, today announced that it will release financial results for the third fiscal quarter of 2026 ended December 31, 2025, before market open on Wednesday, February 4, 2026.
Mosaic Announces Extension of Phosphate Production Curtailments in Brazil
TAMPA, FL / ACCESS Newswire / January 21, 2026 / As previously communicated on December 16th, 2025, due to the recent sharp increase in sulfur prices, Mosaic idled single super phosphate (SSP) production at its Fospar and Araxa facilities in Brazil for an initial 30-day period. Following review, the company has elected to extend these production curtailments by an additional 30 days. Mosaic will continue to assess market conditions in the coming weeks and will evaluate its production plans at that time. Due to the extended curtailment, Mosaic does not intend to purchase sulfur in Brazil in the near term.
BioNxt Reports Final Preclinical Results Demonstrating Approximately 40% Higher Cladribine Delivery for the Treatment Multiple Sclerosis (MS)
VANCOUVER, BC / ACCESS Newswire / January 21, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to report final results from a preclinical pig study demonstrating that its proprietary needle-free, swallow-free sublingual oral dissolvable film (ODF) cladribine formulation for the treatment of Multiple Sclerosis (MS) achieved significantly higher systemic drug delivery than a conventional oral tablet formulation of cladribine, such as those used in commercially successful therapies such as Mavenclad®, which has reported annual global sales exceeding USD 1.2 billion and sustained double-digit growth.
SoftWriters Strengthens Leadership Team with Addition of LiAna Tschen and Strategic Role Expansions
New VP of Platform Operations hire and executive promotions accelerate innovation, operational excellence, and customer success for LTC pharmacy partners.
Dispense Times Releases New Issue Featuring Mark Cuban, Offering Clarity for Independent Pharmacy Owners
New January-February Edition Highlights Transparent Insights on Cost Plus Drugs and the Future of Community Pharmacy
Senegal's 'historic' AFCON champs honoured with parade, presidential praise
Senegal's president congratulated the Lions of Teranga Tuesday for their "historic" victory in the Africa Cup of Nations final against Morocco, after tens of thousands of football fans crowded the streets of Dakar for a celebratory homecoming parade.
Dakar delights in Senegal parade honouring AFCON champions
Tens of thousands of Senegal football fans lined the streets of Dakar on Tuesday as the Lions of Teranga began a victory parade to celebrate their triumph in the Africa Cup of Nations final against Morocco.
Global tourism hit new record level in 2025 despite 'weak' US results: UN
Global tourism hit a new record level in 2025 despite a dip in arrivals in North America due to "weak results" in the United States, UN Tourism said Tuesday.
Royals visit deadly train crash site as Spain mourns
Spain’s king and queen visited Tuesday the site of the collision of two high-speed trains that killed at least 41 people as the country began three days of national mourning.
Global tourism hit new record level in 2025: UN
Global tourism hit a new record level in 2025 with 1.52 billion international tourist arrivals recorded worldwide, driven by strong increases in Asia and Africa, UN Tourism said Tuesday.
Senegal poised to party with parade honouring AFCON champs
After winning the Africa Cup of Nations, Senegal's football players will parade through Dakar on Tuesday, ending their long journey at the country's presidential palace.
Freeze, please! China's winter swimmers take the plunge
As the temperature in Beijing hit -7C on Tuesday, 62-year-old Yang Zi stripped down to his swimming briefs and plunged into a frozen lake, as dozens of residents do every winter.
Spain mourns as train disaster toll rises to 41
Spain began three days of national mourning on Tuesday for 41 people killed after two high-speed trains collided in the country's deadliest train accident in over a decade.
South Koreans go cuckoo for 'Dubai-style' cookies
Chewy, crunchy and not-too-sweet, round, chocolatey "Dubai-style" cookies have become the must-have dessert in South Korea -- with the rush for the snacks even prompting the Red Cross to offer them as a draw for blood donors.
Guatemalans enter state of siege over surge in gang violence
Streets were half-empty Monday in the capital city of Guatemala, where outrage and fear lingered during the first day of the 30-day state of emergency decreed by the government in response to the murder of nine police officers and riots in several prisons.
Belgian court weighs trial for ex-diplomat over Lumumba killing
A Belgian court will hold a hearing Tuesday on whether a former senior diplomat should go on trial over the 1961 killing of Congolese leader Patrice Lumumba.
Spain mourns as train crash toll rises to 40
Spain begins three days of national mourning on Tuesday for the 40 people killed in a high-speed train crash that the prime minister has vowed to investigate.
Tivic CEO To Present at the Upcoming Emerging Growth's January 2026 Virtual Conference
Presentation will Cover Recent Corporate Milestones Including Acceleration of Manufacturing Readiness for Entolimod™
Aytu BioPharma Recaps Investor Day Held on January 20, 2026
DENVER, CO / ACCESS Newswire / January 20, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, today provided a summary of the Company's Investor Day, held today, Tuesday, January 20, 2026, at 11:00 a.m. Eastern time in New York City. The Investor Day was conducted both in-person and via webcast.